{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:55:26Z","timestamp":1781758526797,"version":"3.54.5"},"reference-count":173,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmune hepatitis (AIH) is an immune-mediated chronic liver disease with an increasing incidence. The complex pathogenesis of AIH poses significant challenges for clinical treatment. In recent years, with the introduction of cutting-edge concepts such as \u201cimmune\u2013metabolic interplay\u201d and \u201cintercellular communication networks,\u201d along with novel detection methods and technologies, research on the pathogenesis of AIH has shifted from a single-molecular-mechanism perspective to a systematic regulatory network analysis. This shift has not only provided more research evidence for a deeper understanding of the molecular biological mechanisms underlying AIH but also offers a potential reference for the development of targeted therapeutic drugs for AIH based on novel targets. Therefore, this review starts with aberrant activation signals from key immune cells\u2014including dendritic cells (DCs), macrophages (M\u03c6), and T\/B cells\u2014and integrates the intercellular signaling communication mechanisms between hepatocytes, cholangiocytes, and immune cells to systematically summarize the key molecular biological mechanisms and targets identified in recent years, providing a reference for future elucidation of the critical mechanisms of AIH. On this basis, the review further integrates the current application and research progress of clinically used AIH therapeutic drugs, as well as those at various stages of development, including potential therapeutic compounds. It discusses the limitations of current clinical drugs and evaluates the feasibility and future application potential of potential compounds for AIH treatment in preclinical and clinical studies, thereby offering comprehensive research evidence for the management of AIH.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1871133","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:39:48Z","timestamp":1781757588000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Revealing the pathogenesis of autoimmune hepatitis and research progress in drug discovery from hepatic immune cells and intercellular communication signaling mechanisms"],"prefix":"10.3389","volume":"17","author":[{"given":"Jie","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of China Medical University","place":["Shenyang, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Basic Medical Sciences, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhang","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Medical Security Center, Chinese PLA General Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of China Medical University","place":["Shenyang, Liaoning, China"]},{"name":"Department of Pharmacy, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951x-241","article-title":"Pathology of autoimmune hepatitis","volume":"113","author":"Covelli","year":"2021","journal-title":"Pathologica"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070201","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"380","author":"Muratori","year":"2023","journal-title":"Bmj"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.12.041","article-title":"Update in clinical science: autoimmune hepatitis","volume":"82","author":"Heneghan","year":"2025","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-024-10714-1","article-title":"Acute presentation of autoimmune hepatitis -from acute hepatitis to alf and aclf","volume":"18","author":"Tanaka","year":"2024","journal-title":"Hepatol Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15111","article-title":"Review article: Unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop","volume":"49","author":"Dyson","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29307","article-title":"Regulatory T-cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis\/autoimmune sclerosing cholangitis","volume":"66","author":"Liberal","year":"2017","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-025-10986-1","article-title":"Expanded but dysfunctional regulatory T cells in treatment-naive autoimmune hepatitis","volume":"20","author":"Kwon","year":"2025","journal-title":"Hepatol Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116161","article-title":"Engineering M2 type macrophage-derived exosomes for autoimmune hepatitis immunotherapy via loading siripk3","volume":"171","author":"Zhang","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31739","article-title":"The clinical significance of hepatic cd69(+) cd103(+) cd8(+) resident-memory T cells in autoimmune hepatitis","volume":"74","author":"You","year":"2021","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(20)30328-9","article-title":"Established and novel therapeutic options for autoimmune hepatitis","volume":"6","author":"Liberal","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2015.0040","article-title":"Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis","volume":"22","author":"Park","year":"2016","journal-title":"Clin Mol Hepatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.12.110","article-title":"Protective effects of Punica granatum (pomegranate) peel extract on concanavalin a-induced autoimmune hepatitis in mice","volume":"100","author":"Wang","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30031","article-title":"The impact of autoimmune hepatitis and its treatment on health utility","volume":"68","author":"Wong","year":"2018","journal-title":"Hepatology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/apt.70188","article-title":"Diabetes mellitus in patients with autoimmune hepatitis: frequency, risk factors and effect on outcome","volume":"62","author":"Flatley","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14968","article-title":"Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom","volume":"48","author":"Dyson","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101149","article-title":"External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohort","volume":"6","author":"Grossar","year":"2024","journal-title":"JHEP Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.07.023","article-title":"Second-line and third-line therapy for autoimmune hepatitis: a position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group","volume":"73","author":"Lohse","year":"2020","journal-title":"J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14051","article-title":"Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): is it justified (and in whom and when)","volume":"39","author":"Harrison","year":"2019","journal-title":"Liver Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15970","article-title":"Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: results from the COLHAI registry","volume":"44","author":"Riveiro-Barciela","year":"2024","journal-title":"Liver Int"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2021.1973493","article-title":"Telitacicept as a BLyS\/APRIL dual inhibitor for autoimmune disease","volume":"43","author":"Shi","year":"2021","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/08830185.2023.2274574","article-title":"Low-dose IL-2 therapy in autoimmune diseases: an update review","volume":"43","author":"Zhang","year":"2024","journal-title":"Int Rev Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.08.035","article-title":"Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans","volume":"78","author":"Lim","year":"2023","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2016.11.122","article-title":"Tetramethylpyrazine attenuates carbon tetrachloride-caused liver injury and fibrogenesis and reduces hepatic angiogenesis in rats","volume":"86","author":"Zhao","year":"2017","journal-title":"BioMed Pharmacother"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/cells8111419","article-title":"TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13568-018-0684-2","article-title":"Berberine attenuate staphylococcal enterotoxin B-mediated acute liver injury via regulating HDAC expression","volume":"8","author":"Du","year":"2018","journal-title":"AMB Express"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00462","article-title":"Targeting mechanotransduction at the transcriptional level: YAP and BRD4 are novel therapeutic targets for the reversal of liver fibrosis","volume":"7","author":"Zhubanchaliyev","year":"2016","journal-title":"Front Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.112","article-title":"Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells","volume":"13","author":"Horst","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.814155","article-title":"Impact of antigen presentation mechanisms on immune response in autoimmune hepatitis","volume":"12","author":"Fasano","year":"2021","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103591","article-title":"B and T cells: (still) the dominant orchestrators in autoimmune hepatitis","volume":"23","author":"Longhi","year":"2024","journal-title":"Autoimmun Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102609","article-title":"Can we cure autoimmune hepatitis","volume":"96","author":"Longhi","year":"2025","journal-title":"Curr Opin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9437043","article-title":"Autoimmune hepatitis-immunologically triggered liver pathogenesis-diagnostic and therapeutic strategies","volume":"2019","author":"Sucher","year":"2019","journal-title":"J Immunol Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00018-023-04932-3","article-title":"Metformin induces tolerogenicity of dendritic cells by promoting metabolic reprogramming","volume":"80","author":"Liu","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41419-019-2217-6","article-title":"Critical roles of conventional dendritic cells in autoimmune hepatitis via autophagy regulation","volume":"11","author":"Fan","year":"2020","journal-title":"Cell Death Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14246","article-title":"Deficiency of canonical Wnt\/beta-catenin signalling in hepatic dendritic cells triggers autoimmune hepatitis","volume":"40","author":"Tan","year":"2020","journal-title":"Liver Int"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00773.x","article-title":"Molecular mechanisms of T-cell receptor and costimulatory molecule ligation\/blockade in autoimmune disease therapy","volume":"229","author":"Podojil","year":"2009","journal-title":"Immunol Rev"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00795-005-0289-0","article-title":"Recruitment of dendritic cells to pathological niches in inflamed liver","volume":"38","author":"Yoneyama","year":"2005","journal-title":"Med Mol Morphol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101819-025146","article-title":"Dendritic cell regulation of T helper cells","volume":"39","author":"Yin","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15380","article-title":"The role of macrophage TAM receptor family in the acute-to-chronic progression of liver disease: from friend to foe","volume":"42","author":"Huang","year":"2022","journal-title":"Liver Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114149","article-title":"Allyl methyl disulfide attenuates liver injury induced by concanavalin a by suppressing M1 polarization of macrophages and NLRP3 inflammasome activation","volume":"149","author":"Song","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.803037","article-title":"Macrophage polarization and its role in liver disease","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14871","article-title":"The imbalance of liver resident macrophages polarization promotes chronic autoimmune hepatitis development in mice","volume":"11","author":"Chi","year":"2023","journal-title":"PeerJ"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0578-1426.2017.10.011","article-title":"the study of liver macrophages polarization in patients with autoimmune hepatitis","volume":"56","author":"Guo","year":"2017","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17116","article-title":"Exploring the potential of treating chronic liver disease targeting the PI3K\/AKT pathway and polarization mechanism of macrophages","volume":"9","author":"Yang","year":"2023","journal-title":"Heliyon"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-023-01912-4","article-title":"Manganese exacerbates conA-induced liver inflammation via the cGAS-STING signaling pathway","volume":"47","author":"Saimaier","year":"2024","journal-title":"Inflammation"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00937-5","article-title":"B cells in autoimmune hepatitis: bystanders or central players","volume":"44","author":"Schulthei\u00df","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201802219","article-title":"CD4(+) T cell-released extracellular vesicles potentiate the efficacy of the HBsAg vaccine by enhancing B cell responses","volume":"6","author":"Lu","year":"2019","journal-title":"Adv Sci (Weinh)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100757","article-title":"IL-15-producing splenic B cells play pathogenic roles in the development of autoimmune hepatitis","volume":"5","author":"Fujimori","year":"2023","journal-title":"JHEP Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.14218\/jcth.2022.00235","article-title":"Seronegative autoimmune hepatitis","volume":"11","author":"Bhumi","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2008.00454.x","article-title":"Clinical features of antinuclear antibodies-negative type 1 autoimmune hepatitis","volume":"39","author":"Miyake","year":"2009","journal-title":"Hepatol Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1538555","article-title":"The role of B cell-activating factor system in autoimmune diseases: Mechanisms, disease implications, and therapeutic advances","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0458","DOI":"10.1097\/hc9.0000000000000458","article-title":"Autoimmune hepatitis: Current and future therapies","volume":"8","author":"Reau","year":"2024","journal-title":"Hepatol Commun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e188538","DOI":"10.1172\/jci188538","article-title":"Elucidating the role of autoreactive T cells and B cells in autoimmune hepatitis","volume":"135","author":"Yasumizu","year":"2025","journal-title":"J Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00881-w","article-title":"Functional heterogeneity of Cd4(+) T cells in liver inflammation","volume":"43","author":"Muscate","year":"2021","journal-title":"Semin Immunopathol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746436","article-title":"Dysfunctional immune regulation in autoimmune hepatitis: From pathogenesis to novel therapies","volume":"12","author":"Vuerich","year":"2021","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v16.i11.1225","article-title":"Autoimmune hepatitis: Towards a personalized treatment","volume":"16","author":"Costaguta","year":"2024","journal-title":"World J Hepatol"},{"key":"B57","article-title":"Th1\/Th2 balance: The hypothesis, its limitations, and implications for health and disease","volume":"8","author":"Kidd","year":"2003","journal-title":"Altern Med Rev"},{"key":"B58","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jhep.2017.05.024","article-title":"Crosstalk between type Ii Nkt cells and T cells leads to spontaneous chronic inflammatory liver disease","volume":"67","author":"Weng","year":"2017","journal-title":"J Hepatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.immuni.2022.03.005","article-title":"Differential regulation of transcription factor T-Bet induction during Nk cell development and T helper-1 cell differentiation","volume":"55","author":"Fang","year":"2022","journal-title":"Immunity"},{"key":"B60","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.immuni.2017.05.005","article-title":"The transcription factor T-Bet limits amplification of type I Ifn transcriptome and circuitry in T helper 1 cells","volume":"46","author":"Iwata","year":"2017","journal-title":"Immunity"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e0269","DOI":"10.1097\/hc9.0000000000000269","article-title":"Cd4+ T-cell subsets in autoimmune hepatitis: A review","volume":"7","author":"Chen","year":"2023","journal-title":"Hepatol Commun"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1687755","article-title":"Metabolic reprogramming as a therapeutic target for modulating the Th17\/Treg balance in autoimmune diseases: A comprehensive review","volume":"16","author":"Hu","year":"2025","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev-immunol-101921-045939","article-title":"Tgf-beta regulation of T cells","volume":"41","author":"Chen","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1538\/expanim.22-0171","article-title":"Oroxylin a inhibited autoimmune hepatitis-induced liver injury and shifted Treg\/Th17 balance to Treg differentiation","volume":"72","author":"Zhu","year":"2023","journal-title":"Exp Anim"},{"key":"B65","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.immuni.2020.07.012","article-title":"The conserved non-coding sequences Cns6 and Cns9 control cytokine-induced Rorc transcription during T helper 17 cell differentiation","volume":"53","author":"Chang","year":"2020","journal-title":"Immunity"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-019-00733-8","article-title":"The pathogenicity of Th17 cells in autoimmune diseases","volume":"41","author":"Yasuda","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by Foxp3","volume":"17","author":"Lu","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e2023739118","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed Ctla-4 depletes Cd80\/Cd86 by trogocytosis, releasing free Pd-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.588682","article-title":"The role of Gitr\/Gitrl interaction in autoimmune diseases","volume":"11","author":"Tian","year":"2020","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103085","article-title":"Lymphocyte activation gene-3 (Lag-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases","volume":"21","author":"Gertel","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B71","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/hep.23792","article-title":"A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis","volume":"52","author":"Ferri","year":"2010","journal-title":"Hepatology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2246-4","article-title":"Crispr screen in regulatory T cells reveals modulators of Foxp3","volume":"582","author":"Cortez","year":"2020","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1186\/s40064-016-2512-y","article-title":"Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis","volume":"5","author":"Abe","year":"2016","journal-title":"Springerplus"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14997","article-title":"Dysregulated Tfr and Tfh cells correlate with B-cell differentiation and antibody production in autoimmune hepatitis","volume":"24","author":"Liang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5679254","article-title":"The function of T follicular helper cells in the autoimmune liver diseases","volume":"2020","author":"Li","year":"2020","journal-title":"J Immunol Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02470","article-title":"Molecular control of follicular helper T cell development and differentiation","volume":"9","author":"Wu","year":"2018","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00520","article-title":"Regulators of Tfh cell differentiation","volume":"7","author":"Jogdand","year":"2016","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.70104","article-title":"Il-1\u03b2 and Il-6 synergistically drive murine Tfh cell differentiation and maintenance in vitro","volume":"104","author":"Restrepo Munera","year":"2026","journal-title":"Immunol Cell Biol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9829436","article-title":"Serum cytokine levels and their relation to clinical features in patients with autoimmune liver diseases","volume":"2017","author":"Akberova","year":"2017","journal-title":"J Immunol Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.641013","article-title":"Frontiers of autoantibodies in autoimmune disorders: Crosstalk between Tfh\/Tfr and regulatory B cells","volume":"12","author":"Ding","year":"2021","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2019.01.013","article-title":"Clinical significance and immunobiology of Il-21 in autoimmunity","volume":"99","author":"Long","year":"2019","journal-title":"J Autoimmun"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407284","article-title":"Pd-1(+)Cd8(+) T cell-mediated hepatocyte pyroptosis promotes progression of murine autoimmune liver disease","volume":"12","author":"Long","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12995","article-title":"Cd8(+) T cells actively penetrate hepatocytes via the Cd44\/P-Erm\/F-Actin pathway in autoimmune hepatitis","volume":"22","author":"Liang","year":"2021","journal-title":"J Dig Dis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-026-10353-6","article-title":"Mrna vaccines engage unconventional pathways in Cd8(+) T cell priming","volume":"654","author":"Jo","year":"2026","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-022-00912-y","article-title":"Tox deficiency facilitates the differentiation of Il-17a-producing Gammadelta T cells to drive autoimmune hepatitis","volume":"19","author":"He","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s41232-025-00387-0","article-title":"The impact of T cells on immune-related liver diseases: An overview","volume":"45","author":"Koda","year":"2025","journal-title":"Inflammation Regener"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00910-2","article-title":"Tnf in the liver: Targeting a central player in inflammation","volume":"44","author":"Tiegs","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1694582","article-title":"The pivotal role of cytokines in liver disease pathogenesis and therapeutic potential","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jcmgh.2020.12.003","article-title":"Madcam-1\/Alpha4beta7 integrin-mediated lymphocyte\/endothelium interactions exacerbate acute immune-mediated hepatitis in mice","volume":"11","author":"Schippers","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.378","article-title":"Single-cell Rna sequencing reveals the heterogeneity and intercellular communication of hepatic stellate cells and macrophages during liver fibrosis","volume":"4","author":"Cheng","year":"2023","journal-title":"MedComm (2020)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1152\/physrev.00004.2023","article-title":"The liver as a central \"hub\" of the immune system: Pathophysiological implications","volume":"105","author":"Ronca","year":"2025","journal-title":"Physiol Rev"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3753081","article-title":"The imbalance between Foxp3(+)Tregs and Th1\/Th17\/Th22 cells in patients with newly diagnosed autoimmune hepatitis","volume":"2018","author":"Liang","year":"2018","journal-title":"J Immunol Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2025.103149","article-title":"Context matters: Conflicting roles of interferon-gamma signaling in Cns diseases","volume":"96","author":"Nulman","year":"2026","journal-title":"Curr Opin Neurobiol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.14218\/jcth.2025.00112","article-title":"Protective effect of mesaconate on autoimmune hepatitis via suppression of inflammatory response and oxidative stress","volume":"13","author":"Zhang","year":"2025","journal-title":"J Clin Transl Hepatol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2026.02.026","article-title":"Integrative omics and phase Iia clinical trial identify Tnf as key node in autoimmune hepatitis","author":"Xu","year":"2026","journal-title":"J Hepatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00758","article-title":"Nod-like receptor protein 3 inflammasome-dependent Il-1beta accelerated Cona-induced hepatitis","volume":"9","author":"Luan","year":"2018","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118026","article-title":"Dapansutrile mitigates concanavalin a- induced autoimmune hepatitis: Involvement of Nlrp3\/Il-1\u03b2 and Jnk\/ P38 Mapk pathways","volume":"186","author":"Alenezi","year":"2025","journal-title":"BioMed Pharmacother"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2025.2554663","article-title":"All-trans retinoic acid ameliorates S100-induced experimental autoimmune hepatitis by regulating the Treg\/Th17 balance","volume":"47","author":"Zhao","year":"2025","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.06.008","article-title":"Il-17 and Il-17-producing cells and liver diseases, with focus on autoimmune liver diseases","volume":"17","author":"Beringer","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.17179\/excli2020-3104","article-title":"Immunology of Il-12: An update on functional activities and implications for disease","volume":"19","author":"Ullrich","year":"2020","journal-title":"Excli J"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.982238","article-title":"The regulatory mechanism and potential application of Il-23 in autoimmune diseases","volume":"13","author":"Xiong","year":"2022","journal-title":"Front Pharmacol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-021-06968-6","article-title":"Immune inhibitory properties and therapeutic prospects of transforming growth factor-beta and interleukin 10 in autoimmune hepatitis","volume":"67","author":"Czaja","year":"2022","journal-title":"Dig Dis Sci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02577","article-title":"Interleukin-35 regulates immune microenvironment of autoimmune hepatitis through inducing the expansion of myeloid-derived suppressor cells","volume":"10","author":"Lian","year":"2019","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"uxag013","DOI":"10.1093\/cei\/uxag013","article-title":"An imbalance between Cd80 and Cd86 levels and Cd4 regulatory T cell number and transendocytosis function exists in the liver in autoimmune hepatitis","volume":"220","author":"Halliday","year":"2026","journal-title":"Clin Exp Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.967944","article-title":"Intrahepatic activated leukocyte cell adhesion molecule induces Cd6(high)Cd4(+) T cell infiltration in autoimmune hepatitis","volume":"13","author":"Qian","year":"2022","journal-title":"Front Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.01.002","article-title":"Cellular interactions in self-directed immune-mediated liver diseases","volume":"82","author":"Bozward","year":"2025","journal-title":"J Hepatol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2017.12.006","article-title":"Cytotoxic T lymphocyte antigen-4 gene polymorphisms and susceptibility to type 1 autoimmune hepatitis in the Tunisian population","volume":"5","author":"Chaouali","year":"2018","journal-title":"Genes Dis"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1080\/02648725.2022.2163817","article-title":"Cytotoxic T-lymphocyte associated protein 4 (Ctla4) polymorphisms are linked to systemic lupus erythematosus: An updated meta-analysis","volume":"39","author":"Suvankar","year":"2023","journal-title":"Biotechnol Genet Eng Rev"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939781","article-title":"Abnormal Ctla-4 function in T cells from patients with systemic lupus erythematosus","volume":"40","author":"Jury","year":"2010","journal-title":"Eur J Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-018-9921-7","article-title":"Liver damage related to immune checkpoint inhibitors","volume":"13","author":"Nishida","year":"2019","journal-title":"Hepatol Int"},{"key":"B111","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaut.2018.10.022","article-title":"Novel therapeutic targets in autoimmune hepatitis","volume":"95","author":"Taubert","year":"2018","journal-title":"J Autoimmun"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16574","article-title":"Review article: Targeting the B cell activation system in autoimmune hepatitis","volume":"54","author":"Czaja","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123867","article-title":"Chemokine transfer by liver sinusoidal endothelial cells contributes to the recruitment of Cd4+ T cells into the murine liver","volume":"10","author":"Neumann","year":"2015","journal-title":"PloS One"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812431","article-title":"Functional roles of chemokine receptor Ccr2 and its ligands in liver disease","volume":"13","author":"She","year":"2022","journal-title":"Front Immunol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2009.08.008","article-title":"Immune tolerance: What is unique about the liver","volume":"34","author":"Tiegs","year":"2010","journal-title":"J Autoimmun"},{"key":"B116","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ajpath.2019.09.019","article-title":"The major histocompatibility complex class Ii-Cd4 immunologic synapse in alcoholic hepatitis and autoimmune liver pathology: The role of aberrant major histocompatibility complex class Ii in hepatocytes","volume":"190","author":"Lu","year":"2020","journal-title":"Am J Pathol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"116464","DOI":"10.1016\/j.lfs.2019.05.020","article-title":"Mitochondrial DNA in liver inflammation and oxidative stress","volume":"236","author":"Zhang","year":"2019","journal-title":"Life Sci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000282065","article-title":"Pathology of immune-mediated liver injury","volume":"28","author":"Dienes","year":"2010","journal-title":"Dig Dis"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102619","article-title":"Regulatory T cells in autoimmune hepatitis: An updated overview","volume":"119","author":"Longhi","year":"2021","journal-title":"J Autoimmun"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311247","article-title":"Pgam5-mediated programmed necrosis of hepatocytes drives acute liver injury","volume":"66","author":"He","year":"2017","journal-title":"Gut"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e0491","DOI":"10.1097\/hc9.0000000000000491","article-title":"Liver macrophages revisited: The expanding universe of versatile responses in a spatiotemporal context","volume":"8","author":"Guillot","year":"2024","journal-title":"Hepatol Commun"},{"key":"B122","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jaut.2018.05.001","article-title":"Junctional adhesion molecules Jam-B and Jam-C promote autoimmune-mediated liver fibrosis in mice","volume":"91","author":"Hintermann","year":"2018","journal-title":"J Autoimmun"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.624360","article-title":"Leaky gut driven by dysbiosis augments activation and accumulation of liver macrophages via Rip3 signaling pathway in autoimmune hepatitis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1097\/ms9.0000000000003709","article-title":"Gut microbial signatures in autoimmune hepatitis: Unlocking diagnostic and therapeutic potential","volume":"87","author":"Iftikhar","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317836","article-title":"Alterations of gut microbiome in autoimmune hepatitis","volume":"69","author":"Wei","year":"2020","journal-title":"Gut"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1337223","article-title":"The significance of gut microbiota in the etiology of autoimmune hepatitis: A narrative review","volume":"14","author":"Sun","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.31083\/fbl27747","article-title":"Gut barrier, microbial metabolites, and immune homeostasis in autoimmune hepatitis: From molecular mechanisms to strategies","volume":"30","author":"Zhang","year":"2025","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i38.5896","article-title":"Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations","volume":"26","author":"Abdollahi","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15528","article-title":"Adverse events related to low dose corticosteroids in autoimmune hepatitis","volume":"50","author":"van den Brand","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001074","article-title":"Boosting success: Optimizing thiopurine therapy in autoimmune hepatitis with allopurinol","volume":"80","author":"Malhi","year":"2024","journal-title":"Hepatology"},{"key":"B131","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12026-025-09622-9","article-title":"Clinical management of autoimmune liver diseases: Juncture, opportunities, and challenges ahead","volume":"73","author":"Chen","year":"2025","journal-title":"Immunol Res"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.7499\/j.issn.1008-8830.2019.01.018","article-title":"Significance of Nudt15 gene in individualized treatment with 6-mercaptopurine in children with acute lymphoblastic leukemia","volume":"21","author":"He","year":"2019","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1159\/000440752","article-title":"Aih: Which alternative for difficult-to-treat patients","volume":"33","author":"Sebode","year":"2015","journal-title":"Dig Dis"},{"key":"B134","doi-asserted-by":"publisher","first-page":"493","DOI":"10.14218\/jcth.2025.00008","article-title":"The role of novel immunomodulators in the treatment of autoimmune hepatitis","volume":"13","author":"Li","year":"2025","journal-title":"J Clin Transl Hepatol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2017.1333595","article-title":"Challenges and opportunities in targeting the Cd28\/Ctla-4 pathway in transplantation and autoimmunity","volume":"17","author":"Crepeau","year":"2017","journal-title":"Expert Opin Biol Ther"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112659","article-title":"Fkbp38 deletion exacerbates Cona-induced hepatitis by promoting the immune response through the Mcp-1\/P38 pathway","volume":"138","author":"Wang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01889","article-title":"Immunometabolic checkpoints of Treg dynamics: Adaptation to microenvironmental opportunities and challenges","volume":"10","author":"Pacella","year":"2019","journal-title":"Front Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10750","article-title":"The Jak inhibitor tofacitinib ameliorates immune-mediated liver injury in mice","volume":"20","author":"Wang","year":"2019","journal-title":"Mol Med Rep"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-023-01327-5","article-title":"A low dose of naloxone mitigates autoimmune hepatitis by regulating Tlr4\/Nf-Kb and Nrf2\/Ho-1 signaling pathways","volume":"31","author":"Ibrahim","year":"2023","journal-title":"Inflammopharmacology"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001089","article-title":"Efficacy and safety of infliximab in patients with autoimmune hepatitis","volume":"81","author":"Efe","year":"2025","journal-title":"Hepatology"},{"key":"B141","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1053\/j.gastro.2010.04.053","article-title":"Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis","volume":"139","author":"Czaja","year":"2010","journal-title":"Gastroenterology"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103113","article-title":"Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis","volume":"140","author":"Terziroli Beretta-Piccoli","year":"2023","journal-title":"J Autoimmun"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i7.926","article-title":"Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy","volume":"7","author":"Purohit","year":"2015","journal-title":"World J Hepatol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2017.07.012","article-title":"Jkb-122 is effective, alone or in combination with prednisolone in Con a-induced hepatitis","volume":"812","author":"Hsu","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.08.001","article-title":"Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis","volume":"1","author":"Oo","year":"2019","journal-title":"JHEP Rep"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.833878","article-title":"Mesenchymal stem cell-derived extracellular vesicles in liver immunity and therapy","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116982","article-title":"Pirfenidone alleviates concanavalin a-induced liver fibrosis in mice","volume":"239","author":"Salah","year":"2019","journal-title":"Life Sci"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01127-22","article-title":"A novel synbiotic alleviates autoimmune hepatitis by modulating the gut microbiota-liver axis and inhibiting the hepatic Tlr4\/Nf-Kb\/Nlrp3 signaling pathway","volume":"8","author":"Kang","year":"2023","journal-title":"mSystems"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.947382","article-title":"The gut microbiota: A novel player in autoimmune hepatitis","volume":"12","author":"Cheng","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155722","article-title":"Naringin as a natural candidate for anti-autoimmune hepatitis: Inhibitory potency and hepatoprotective mechanism","volume":"129","author":"Zhu","year":"2024","journal-title":"Phytomedicine"},{"key":"B151","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12026-025-09689-4","article-title":"Piceatannol improves autoimmune hepatitis by inhibiting the immune activities of T cells and macrophages through binding with C-Jun","volume":"73","author":"Xu","year":"2025","journal-title":"Immunol Res"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155586","article-title":"Glycyrrhizic acid alleviates concanavalin a-induced acute liver injury by regulating monocyte-derived macrophages","volume":"133","author":"Lu","year":"2024","journal-title":"Phytomedicine"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403148","article-title":"Astaxanthin alleviates autoimmune hepatitis by modulating cd8(+) T cells: Insights from mass cytometry and single-cell rna sequencing analyses","volume":"11","author":"He","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B154","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3892\/ijmm.2023.5281","article-title":"Sophoricoside attenuates autoimmune-mediated liver injury through the regulation of oxidative stress and the nf-\u03bab signaling pathway","volume":"52","author":"Chen","year":"2023","journal-title":"Int J Mol Med"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113198","article-title":"Zingerone attenuates concanavalin a-induced acute liver injury by restricting inflammatory responses","volume":"142","author":"Liu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-024-02021-6","article-title":"Succinic acid ameliorates concanavalin a-induced hepatitis by altering the inflammatory microenvironment and expression of bcl-2 family proteins","volume":"47","author":"Cai","year":"2024","journal-title":"Inflammation"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2022.104517","article-title":"D-mannose administration improves autoimmune hepatitis by upregulating regulatory T cells","volume":"375","author":"Ito","year":"2022","journal-title":"Cell Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2022.2093741","article-title":"Gastrodin ameliorates concanavalin a-induced acute hepatitis via the il6\/jak2\/stat3 pathway","volume":"44","author":"Zhou","year":"2022","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157273","article-title":"3-o-acetyloleanolic acid alleviates autoimmune liver injury by targeting fxr","volume":"148","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102904","article-title":"Zvad alleviates experimental autoimmune hepatitis in mice by increasing the sensitivity of macrophage to tnfr1-dependent necroptosis","volume":"133","author":"Li","year":"2022","journal-title":"J Autoimmun"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17551","article-title":"Itaconate attenuates autoimmune hepatitis via pi3k\/akt\/mtor pathway-mediated inhibition of dendritic cell maturation and autophagy","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113826","article-title":"Sulforaphane regulation autophagy-mediated pyroptosis in autoimmune hepatitis via ampk\/mtor pathway","volume":"146","author":"Yang","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115795","article-title":"Nimbolide attenuated the inflammation in the liver of autoimmune hepatitis's mice through regulation of hdac3","volume":"434","author":"Xia","year":"2022","journal-title":"Toxicol Appl Pharmacol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.972397","article-title":"Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of grk2 with pi3k in T lymphocytes","volume":"13","author":"Jin","year":"2022","journal-title":"Front Pharmacol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174720","article-title":"Vitexin attenuates autoimmune hepatitis in mouse induced by syngeneic liver cytosolic proteins via activation of ampk\/akt\/gsk-3\u03b2\/nrf2 pathway","volume":"917","author":"Zhang","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14062","article-title":"Autoimmune hepatitis: Current and future therapeutic options","volume":"39","author":"Doycheva","year":"2019","journal-title":"Liver Int"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4675-y","article-title":"Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis","volume":"62","author":"Czaja","year":"2017","journal-title":"Dig Dis Sci"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31985","article-title":"We are not immune: Racial and ethnic disparities in autoimmune liver diseases","volume":"74","author":"Lee","year":"2021","journal-title":"Hepatology"},{"key":"B169","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/biology15050400","article-title":"Autoimmune hepatitis: A review of molecular mechanisms and research gaps in African populations","volume":"15","author":"Wheeler","year":"2026","journal-title":"Biol (Basel)"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.cppeds.2014.10.005","article-title":"Autoimmune hepatitis: A classic autoimmune liver disease","volume":"44","author":"Moy","year":"2014","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23536","article-title":"Forkhead box P3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis","volume":"51","author":"Lapierre","year":"2010","journal-title":"Hepatology"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01567","article-title":"The effects of androgens on T cells: Clues to female predominance in autoimmune liver diseases","volume":"11","author":"Henze","year":"2020","journal-title":"Front Immunol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.6ri0319-094r","article-title":"When the balance is broken: X-linked gene dosage from two X chromosomes and female-biased autoimmunity","volume":"106","author":"Syrett","year":"2019","journal-title":"J Leukoc Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1871133\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:39:57Z","timestamp":1781757597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1871133\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":173,"alternative-id":["10.3389\/fimmu.2026.1871133"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1871133","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"article-number":"1871133"}}